中国腹腔镜减重与代谢外科起步于20年前，经过10余年的萌芽期，现已经进入快速发展早期，标志是开展本专业的医院和医生数量快速增长和年手术量的快速增长。在过去20年间，我国所开展的减重与代谢手术方式以标准术式为主，近些年一些新型手术方式在一些中心也有开展；在学科起步之初，本学科即在中华医学会外科学分会内分泌外科学组架构之下，进行质控和标准化建设，2012年成立了首个专业的学术组织—中国医师协会外科医师分会肥胖和糖尿病外科专业委员会，此后多个国家专业学会相继成立，对本学科的普及起了巨大的推动作用；从最早的内分泌外科学组到目前，本学科领域制定了多部临床指南性文件，对学科的规范发展起到重要作用。目前减重与代谢外科在我国作为一个年轻的学科，未来在临床数据的收集、临床研究的开展、系统性的结构化专科培训以及临床质量控制和病人安全不断提升需要不断开展工作，以促进本学科科学规范发展，为肥胖症及肥胖相关疾病患者提供更优质更安全的医疗服务。

Laparoscopic metabolic and bariatric surgery (MBS) in China started 20 years ago. After more than 10 years of incubation, it has entered the early stage of rapid development, which is marked by the rapid growth of the number of hospitals and doctors involved and the rapid growth of annual operation volume. During the past 20 years, MBS operations were mainly standard operations in China.In recent years, however, some new surgical procedures have also been carried out in some centers. During the early time of development in China, MBS was under the framework of Chinese Association of EndocrineSurgery for quality control and standardization. In 2012, the first professional academic organization, the Chinese Society of Metabolic and Bariatric Surgery (CSMBS) was established. Since then, a few other national professional societies have been established, which has greatly promoted the awareness of MBS in the public. From the earliest Chinese Association of EndocrineSurgeryto the present, a number of clinical practice guidance documents have been formulated, which plays an important role in the regulation ofstandardized development of MBS. So far, MBS is still an emerging discipline in China. In the coming years, clinical data collection, clinical research, systematic structuredtraining, clinical quality control and patient safety improvement need to be continuously emphasized to promote the healthy development of MBS, and ultimately provide better quality and safer medical care for patients with obesity and obesity related diseases.